Insulet’s Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

view original post

Insulet (PODD) excels with strong Q2 results, Omnipod 5 app launch, and >20% growth outlook. Read here for an investment analysis.